X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
https://www.fiercepharma.com/pharma/abbvies-humira-takes-back-its-top-spot-icers-annual-list-unsupported-price-hikes
https://www.gene.com/media/press-releases/15012/2023-12-08/genentechs-inavolisib-combination-reduce
https://www.globenewswire.com/news-release/2023/12/05/2791260/0/en/Olema-Oncology-Announces-Palazestrant-Demonstrates-Attractive-Combinability-with-CDK4-6-Inhibitors-Ribociclib-and-Palbociclib-in-Phase-1b-2-Studies.html
https://www.globenewswire.com/news-release/2023/05/30/2678864/0/en/Olema-Oncology-to-Present-at-the-2023-Jefferies-Healthcare-Conference.html
https://www.globenewswire.com/news-release/2023/05/11/2666748/0/en/Olema-Oncology-Announces-OP-1250-Continues-to-Demonstrate-Attractive-Combinability-with-CDK4-6-Inhibitor-Palbociclib-in-Phase-1b-2-Study.html
https://www.reuters.com/business/healthcare-pharmaceuticals/bristol-myers-pfizer-abbvie-drugs-likely-face-us-price-negotiation-2023-03-13/
https://www.fiercepharma.com/pharma/mysterious-approval-pfizer-quietly-wins-ibrance-breast-cancer-expansion-after-fda-requested
https://www.biospectrumindia.com/news/73/22492/msn-group-launches-worlds-first-generic-drug-for-advanced-breast-cancer-therapy.html
https://www.indianpharmapost.com/news/dr-reddys-acquires-trademark-rights-of-breast-cancer-drug-primcyv-from-pfizer-13595
https://www.indianpharmapost.com/news/sun-pharma-launches-palbociclib-a-novel-targeted-therapy-for-advanced-breast-cancer-13586
https://www.biopharmadive.com/news/pharma-drug-price-increases-january-new-year/639564/
https://www.globenewswire.com//news-release/2022/12/07/2569695/0/en/Olema-Oncology-Announces-OP-1250-Demonstrates-Attractive-Combinability-with-CDK-4-6-Inhibitor-Palbociclib-in-Phase-1b-Dose-Escalation-Study.html
https://www.globenewswire.com/news-release/2022/10/20/2538289/0/en/Erasca-Announces-Clinical-Trial-Collaboration-and-Supply-Agreement-with-Pfizer-to-Evaluate-ERAS-007-and-Palbociclib-Combination.html
https://www.pharmaceutical-technology.com/news/nice-approval-breast-cancer-drug/
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213086
https://www.fiercepharma.com/marketing/eli-lillys-verzenio-further-pressures-pfizer-nice-backing-postsurgery-breast-cancer
https://www.fiercepharma.com/pharma/asco-pfizers-ibrance-fails-extend-lives-newly-diagnosed-breast-cancer-will-doctors-switch
https://www.europeanpharmaceuticalreview.com/news/171160/ibrance-improves-survival-in-breast-cancer-patients/
https://www.pharmacompass.com/pdf/news/celcuity-announces-clinical-trial-collaboration-and-supply-agreement-with-pfizer-to-provide-ibrancer-palbociclib-for-planned-phase-3-clinical-tria-1638787237.pdf
https://pharmaphorum.com/news/fda-posts-guidance-on-mining-real-world-data-from-health-records/
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213091
https://www.sharecast.com/news/Company-Announcement-General/Progress-on-metastatic-breast-cancer-programme--dl31914105.html
https://www.fiercepharma.com/marketing/pfizer-s-ibrance-under-threat-from-novartis-and-lilly-leans-real-world-data-breast-cancer
https://endpts.com/novartis-cdk4-6-med-kisqali-firmly-the-sales-underdog-against-pfizers-ibrance-drops-big-os-data/
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/pfizer-moves-us-court-against-aurobindo-pharma-dr-reddys-on-cancer-drug/articleshow/79257595.cms?from=mdr
https://www.prnewswire.com/news-releases/olema-oncology-announces-clinical-trial-agreement-to-evaluate-op-1250-in-combination-with-palbociclib-ibrance-in-advanced-metastatic-breast-cancer-301172877.html
https://www.globenewswire.com/news-release/2020/11/04/2120344/0/en/Calithera-Biosciences-Announces-Expansion-of-Ongoing-Clinical-Trial-Evaluating-Telaglenastat-in-Combination-with-palbociclib-IBRANCE.html
https://www.reuters.com/article/us-pfizer-study/pfizers-breast-cancer-drug-ibrance-fails-late-stage-study-idUSKBN26U15G
https://www.zyduscadila.com/public/pdf/pressrelease/Press-Release-for-Palbociclib-Capsules.pdf
https://www.moneycontrol.com/news/business/zydus-cadila-gets-tentative-usfda-nod-to-market-anti-cancer-drug-5878851.html
https://www.fiercepharma.com/pharma/vyndaqel-and-other-drugs-boost-pfizer-s-business-as-it-eyes-covid-19-vaccine-launch-year
https://www.reuters.com/article/us-pfizer-stocks/pfizer-declines-about-8-after-setback-to-breast-cancer-treatment-idUSKBN2382U6
https://investors.pfizer.com/investor-news/press-release-details/2020/New-Data-from-18-Approved-and-Investigational-Pfizer-Medicines-to-be-Showcased-at-ASCO20-Virtual-Scientific-Program/default.aspx
https://www.prnewswire.com/news-releases/alliancerx-walgreens-prime-studies-the-use-of-cyclin-dependent-kinase-46-inhibitors-in-breast-cancer-patients-301056092.html
https://www.prnewswire.com/news-releases/alphamab-oncology-announces-clinical-supply-collaboration-with-pfizer-on-kn026-in-combination-with-ibrancer-palbociclib-301030809.html
https://www.fiercepharma.com/pharma/merck-s-keytruda-faces-nice-pushback-as-treatment-for-head-and-neck-cancer
https://www.fiercepharma.com/pharma/sabcs-pfizer-s-ibrance-backs-up-benefit-her2-negative-breast-cancer-real-world-data
http://www.pharmatimes.com/news/nice_approves_ibrance_via_cancer_drugs_fund_1318368
http://www.pharmafile.com/news/534514/pfizer-s-ibrance-approved-nice-be-added-cancer-drugs-fund
https://endpts.com/novartis-eli-lilly-marquee-positive-survival-data-for-cdk-4-6-franchises-but-can-they-actually-beat-pfizers-blockbuster/
https://press.pfizer.com/press-release/pfizer-presents-new-evidence-ibrance-palbociclib-effectiveness-hr-her2-metastatic-brea
http://www.pmlive.com/pharma_news/half_of_european_cancer_drug_trials_biased,_says_bmj_1302096
Market Place
Share 
